Trodelvy (sacituzumab govitecan-hziy) is a targeted therapy designed to treat metastatic triple-negative breast cancer (MTNBC), a particularly aggressive form of breast cancer. MTNBC is a subtype of breast cancer that does not respond to the usual hormone treatments, making it difficult to treat. Traditional treatments like chemotherapy are often used, but these come with significant…
Trodelvy is an innovative treatment that has shown promise in treating metastatic triple-negative breast cancer (MTNBC). This type of breast cancer is known for being more aggressive and harder to treat than other forms. Trodelvy, a targeted therapy, has emerged as a groundbreaking option for patients who have limited treatment options. Trodelvy has changed the…
